Sage Therapeutic
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $31,660 | $14,063 | $12,816 | $11,871 |
Gross Profit | 31,715 | 13,408 | 11,327 | 6,593 |
EBITDA | -54,095 | -67,455 | -80,211 | -101,202 |
EBIT | -54,199 | -67,567 | -80,340 | -101,457 |
Net Income | -49,652 | -62,214 | -95,778 | -93,551 |
Net Change In Cash | 31,660 | 14,063 | 12,816 | 11,871 |
Free Cash Flow | -58,690 | -81,728 | -66,560 | -82,365 |
Cash | 67,487 | 45,224 | 81,021 | 99,627 |
Basic Shares | 62,610 | 61,858 | 60,766 | 61,116 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $41,243 | $86,455 | $7,686 | $6,308 |
Gross Profit | 31,799 | 84,296 | 6,873 | 5,755 |
EBITDA | -409,485 | -545,070 | -545,867 | -456,727 |
EBIT | -410,516 | -546,463 | -546,989 | -460,909 |
Net Income | -400,666 | -541,489 | -503,267 | -450,827 |
Net Change In Cash | 41,243 | 86,455 | 7,686 | 6,308 |
Cost of Revenue | -131,533 | -1,367,296 | ||
Free Cash Flow | -267,194 | -541,138 | -460,973 | -378,554 |
Cash | 81,021 | 70,992 | 162,700 | 294,233 |
Basic Shares | 60,766 | 59,836 | 59,306 | 58,670 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.79 |
2025-03-31 | -$0.99 |
2024-12-31 | -$1.19 |
